Litcius/Paper detail

Maintaining Safety with SARS-CoV-2 Vaccines

Mariana Castells, Elizabeth J. Phillips

2020New England Journal of Medicine403 citationsDOIOpen Access PDF

Abstract

The following table lists substances, other than active ingredients (i.e., antigens), shown in the manufacturers' package insert (PI) as being contained in the final formulation of each vaccine.Substances used in the manufacture of a vaccine but not listed as contained in the final product (e.g., culture media) can be found in each PI, but are not shown on this table.Each PI, which can be found on the FDA's website (see below) contains a description of that vaccine's manufacturing process, including the amount and purpose of each substance.In most PIs, this information is found in Section 11: "Description." Please refer to the PI for a complete list of ingredients or excipients.

Topics & Concepts

Package insertCoronavirus disease 2019 (COVID-19)Table (database)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Product (mathematics)2019-20 coronavirus outbreakSection (typography)VirologyManufacturing processGood manufacturing practiceComputer scienceBusinessMedicineMathematicsDatabasePharmacologyOperating systemMaterials scienceMarketingInfectious disease (medical specialty)Supply chainOutbreakPathologyComposite materialDiseaseGeometrySARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyVaccine Coverage and Hesitancy